Keep up to date with news from Gamma Gurus — Announcements

After a well deserved maternity leave, we're so elated to have Nicole Pritchard back on board that we also gave her a promotion!  Nicole is now our Head Radiotherapy Product Guru and will be focussing on key accounts as well as continuing to manage sales of our clinical radiotherapy protfolio. Joining Nicole is Louis Shu who is also a trained Radiation Therapist and has joined us from the Peter MacCallum Cancer Centre.  Louis will be taking over some of Nicole's day-to-day customer interactions and will ensure our high level of customer service is maintained as our product range continues to grow.

Late 2022, CIVCO RT and Qfix announced the merger of their two companies to become a joint manufacturer offering the best of both product ranges - "Better Together".  Gamma Gurus is very pleased to announce that we have been selected to carry both Qfix and CIVCO RT lines in the Australian and New Zealand markets.  We look forward to offering expanded options for our customers such as the innovative Alta™, Access™ & Encompass™ (validated for HyperArc™). Qfix – Gamma Gurus

Gamma Gurus is very pleased to announce the signing of an agency agreement with Bruker BioSpin to market their portfolio of Nuclear Molecular Imaging (NMI) products in Australia & New Zealand. This expands our ability to support the preclinical NMI field by adding additional products, including PET/MR, to the already successful Molecubes range that was acquired by Bruker in November 2021. We look forward to introducing these new products to our customers in 2023!

Louvain-La-Neuve, Belgium, 26 August, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that the Company is the only proton therapy equipment supplier that has qualified for the second round of a significant public tender launched by the Spanish Ministry of Health. This public tender is aimed at selecting one or several proton therapy suppliers to install 10 proton therapy units across the country. The Spanish Ministry of Health has published the results of the first round of selection of the...

RadTat is the first non-invasive, semi-permanent skin marking for radiation oncology and Gamma Gurus is pleased to be able to offer this innovative product in Australia. RadTats were designed with both patients and providers in mind as a simple and painless alternative to permanent tatoos that will last for up to two weeks with little to no maintenance by patient or care provider. This is not a sticker! RadTat provides a quick, simple solution that lasts! RadTat Semi-permanent Skin Marking – Gamma Gurus